Bizacumen Inc., Nov 2009, Pages: 305
)
Janssen-Cilag (Switzerland)
Merck & Co., Inc. (USA)
NeurocrineBiosciences, Inc. (USA)
Novartis AG (Switzerland)
Sandoz International GmbH (Germany)
Organon N.V. (The Netherlands)
Ortho-Mc
Wright Investors' Service, Sep 2010, Pages: 40
Altus Pharmaceuticals Inc., BioTime, Inc. and NeurocrineBiosciencesInc. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations
Wright Investors' Service, Sep 2010, Pages: 50
Pharmaceuticals Inc. versus NeurocrineBiosciencesInc, BioTime, Inc. and Inhibitex, Inc.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company
Wright Investors' Service, Sep 2010, Pages: 40
America, Inc. versus NeurocrineBiosciencesInc, Oculus Innovative Sciences, Inc. and Immunomedics, Inc.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per
NeuroInsights, May 2010
Markets
Now in its sixth year, The Neurotechnology Industry 2010 Report is an expanded and updated 500 page report of brain and nervous system markets and treatments. It is the only publication to provide
Life Science Analytics, March 2008, Pages: 47
NeurocrineBiosciencesInc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products
Drug and Market Development Publishing, Nov 2004, Pages: 250
Neil)
Laxdale, Ltd.
Lundbeck (H. Lundbeck A/S)
MediciNova, Inc.
Memory Pharmaceuticals Corporation
Merck & Co., Inc.
Merck KgaA
Nabi Biopharmaceuticals, Inc.
Nastech Pharmaceutical Co., Inc.
Neurocrine